Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria
Public ClinicalTrials.gov record NCT03118739. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effects of Intensive Uric Acid Lowering Therapy With RDEA3170 (Verinurad) and Febuxostat in Patients With Albuminuria
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to evaluate signals of potential clinical benefit of the combination of Verinurad and Febuxostat in lowering concentrations of circulating uric acid and thus improving kidney or cardiovascular status of patients with hyperuricemia, albuminuria, and Type 2 diabetes (T2DM).
Study identification
- NCT ID
- NCT03118739
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 18, 2017 (Actual)
- Primary completion
- Aug 13, 2018 (Actual)
- Completion
- Aug 13, 2018 (Actual)
- Last update posted
- Jan 10, 2020
2017 – 2018
United States locations
- U.S. sites
- 18
- U.S. states
- 2
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Canyon Country | California | 91351 | — |
| Research Site | Chula Vista | California | 91911 | — |
| Research Site | Corona | California | 92882 | — |
| Research Site | Escondido | California | 92025 | — |
| Research Site | Lakewood | California | 90805 | — |
| Research Site | Lincoln | California | 95648 | — |
| Research Site | Los Angeles | California | 90017 | — |
| Research Site | Los Angeles | California | 90022 | — |
| Research Site | Los Angeles | California | 90036 | — |
| Research Site | North Hollywood | California | 91606 | — |
| Research Site | Oceanside | California | 92056-4510 | — |
| Research Site | Orange | California | 92868 | — |
| Research Site | Sacramento | California | 95821 | — |
| Research Site | Houston | Texas | 77058 | — |
| Research Site | Houston | Texas | 77070 | — |
| Research Site | Pearland | Texas | 77584 | — |
| Research Site | Sugar Land | Texas | 77478 | — |
| Research Site | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03118739, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 10, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03118739 live on ClinicalTrials.gov.